Eris Lifesciences Limited — Board Meeting, 12-11-2025: Outcome of Board Meeting
12-11-2025 | 01:46 pm
12-11-2025 | 01:46 pm
Eris Lifesciences board cleared Q2/H1 FY26 consolidated financials: Q2 Net Profit Rs 134.47 Cr, H1 Net Profit Rs 259.57 Cr. Directors Krishnakumar Vaidyanathan (WTD) & Kalpana Unadkat (ID) proposed for re-appointment for 5-year terms, pending shareholder vote.
No comments yet. Be the first to comment!
